The future of neurosurgical oncology lies in cognitive neurosciences: understanding brain processing is much more valuable than surgical technology - Report - MDSpire

The future of neurosurgical oncology lies in cognitive neurosciences: understanding brain processing is much more valuable than surgical technology

  • By

  • Hugues Duffau

  • June 11, 2026

  • 0 min

Share

Clinical Report: Advancing Neurosurgical Oncology Through Cognitive Neuroscience

Overview

This report emphasizes the need to integrate cognitive neuroscience into glioma surgery to enhance both quality of life (QoL) and overall survival (OS) for patients. Traditional surgical approaches focused on tumor removal have not consistently improved long-term outcomes, highlighting the necessity for a paradigm shift in neuro-oncology.

Background

Glioma surgery has historically prioritized tumor resection over patient QoL, often leading to suboptimal outcomes. The reliance on progression-free survival (PFS) and time to next intervention (TNI) as surrogates for OS has proven inadequate, particularly in low-grade gliomas. A new approach that incorporates cognitive neuroscience could better balance surgical efficacy with functional preservation.

Data Highlights

No numerical data or trial data provided in the source material.

Key Findings

  • Traditional glioma surgery has focused on tumor removal, often neglecting the functional implications for patients.
  • Surrogates like PFS and TNI do not reliably predict OS, particularly in low-grade gliomas.
  • Functional neuroimaging techniques have limitations in accurately identifying critical brain areas that must be preserved during surgery.
  • Alternative surgical philosophies that prioritize functional outcomes have shown prolonged OS while maintaining active life for patients.
  • Integration of cognitive neuroscience into surgical planning could optimize both QoL and OS for glioma patients.

Clinical Implications

Surgeons should consider a shift towards functional connectome-based approaches in glioma surgery to improve patient outcomes. Emphasizing cognitive preservation alongside tumor resection may lead to better long-term survival and QoL for patients.

Conclusion

Incorporating cognitive neuroscience into neurosurgical oncology represents a critical advancement in the management of glioma patients, aiming to enhance both survival and functional outcomes. A paradigm shift is necessary to address the onco-functional dilemma in surgical neurooncology.

Related Resources & Content

  1. Awake Tumor Resection Utilizing Direct Electrical Stimulation Mapping and Real-Time Cognitive Assessment: Our Approach, Springer, 2025
  2. Utilizing Indirect Cognitive Mapping Techniques in Glioma Surgery for Patients Ineligible for Awake Craniotomy – My Approach, Springer, 2025
  3. Innovations in Artificial Intelligence for Neurosurgical Oncology: A Comprehensive Review, Journal of Neuro-Oncology, 2024
  4. Improving Treatment and Care for Patients with Primary Brain Cancers, ASCO Post, 2013
  5. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial, PubMed, 2006
  6. Multiscale network perspectives on glioma: from tumour biology to symptoms, survival and treatment, Nature Reviews Neurology, 2025
  7. 2025 Joint EANS–EANO Guideline on Glioma Resection
  8. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial - PubMed
  9. Multiscale network perspectives on glioma: from tumour biology to symptoms, survival and treatment | Nature Reviews Neurology

Original Source(s)

Related Content